Name: Acura Pharmaceuticals EBITDA 2010-2021 | ACUR
Creator: MACROTRENDS
License: https://creativecommons.org/licenses/by/4.0/

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Acura Pharmaceuticals ebitda from 2010 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$15.5B
Dr Reddy's Laboratories (RDY)	$11.4B
BridgeBio Pharma (BBIO)	$6.4B
Bausch Health Cos (BHC)	$1.9B
Supernus Pharmaceuticals (SUPN)	$1.7B
Amphastar Pharmaceuticals (AMPH)	$1.1B
Personalis (PSNL)	$282M
Taysha Gene Therapies (TSHA)	$254M
Assembly Biosciences (ASMB)	$75M
Sol-Gel Technologies (SLGL)	$15M
Evoke Pharma (EVOK)	$3M
Teligent (TLGT)	$0M

Recent Trends